Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Net Margin (2016 - 2020)

Historic Net Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 5226.32%.

  • Syndax Pharmaceuticals' Net Margin fell 14881600.0% to 5226.32% in Q4 2020 from the same period last year, while for Sep 2021 it was 5226.32%, marking a year-over-year decrease of 8909200.0%. This contributed to the annual value of 1346.11% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported Net Margin of 5226.32% as of Q4 2020, which was down 14881600.0% from 5238.26% recorded in Q3 2020.
  • Syndax Pharmaceuticals' 5-year Net Margin high stood at 1594.89% for Q4 2017, and its period low was 5238.26% during Q3 2020.
  • Its 5-year average for Net Margin is 4162.45%, with a median of 4309.0% in 2017.
  • Per our database at Business Quant, Syndax Pharmaceuticals' Net Margin skyrocketed by 317537900bps in 2016 and then crashed by -34927400bps in 2018.
  • Syndax Pharmaceuticals' Net Margin (Quarter) stood at 3564.92% in 2016, then surged by 55bps to 1594.89% in 2017, then crashed by -219bps to 5087.63% in 2018, then increased by 27bps to 3738.16% in 2019, then tumbled by -40bps to 5226.32% in 2020.
  • Its last three reported values are 5226.32% in Q4 2020, 5238.26% for Q3 2020, and 4382.59% during Q2 2020.